Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
LFMD LifeMD Inc
- Stocks
- Healthcare
- NASDAQ: LFMD
Price (delayed)
$10.72
Market cap
$487.2M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.33
Enterprise value
$477.9M
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable
Highlights
The EPS has soared by 55% YoY and by 38% from the previous quarter
LifeMD's net income has surged by 54% YoY and by 43% QoQ
LifeMD's equity has shrunk by 175% YoY but it has surged by 58% QoQ
The debt is up by 26% year-on-year
The quick ratio has contracted by 20% YoY
Key stats
What are the main financial stats of LFMD
Market
Valuations
Earnings
Shares outstanding
45.45M
Market cap
$487.2M
Enterprise value
$477.9M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.98
EV/EBIT
N/A
EV/EBITDA
152.93
EV/Sales
2.04
Revenue
$234.01M
Gross profit
$205.9M
Operating income
-$7.43M
Net income
-$10.73M
EBIT
-$8M
EBITDA
$3.13M
Free cash flow
$3.17M
Per share
Balance sheet
Liquidity
EPS
-$0.33
EPS diluted
-$0.33
Free cash flow per share
$0.07
Book value per share
-$0.05
Revenue per share
$5.42
TBVPS
$1.33
Total assets
$73.61M
Total liabilities
$74.01M
Debt
$25.1M
Equity
-$2.33M
Working capital
-$10.93M
Debt to equity
-10.78
Current ratio
0.82
Quick ratio
0.73
Net debt/EBITDA
-2.97
Margins
Efficiency
Dividend
EBITDA margin
1.3%
Gross margin
88%
Net margin
-4.6%
Operating margin
-3.2%
Return on assets
-19.6%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-62.9%
Return on sales
-3.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFMD stock price
How has the LifeMD stock price performed over time
Intraday
10.86%
1 week
29.78%
1 month
113.12%
1 year
38.86%
YTD
116.57%
QTD
97.06%
Financial performance
How have LifeMD's revenue and profit performed over time
Revenue
$234.01M
Gross profit
$205.9M
Operating income
-$7.43M
Net income
-$10.73M
Gross margin
88%
Net margin
-4.6%
LFMD's operating margin has soared by 71% year-on-year and by 58% since the previous quarter
The net margin has surged by 68% year-on-year and by 48% since the previous quarter
LFMD's operating income has soared by 58% YoY and by 54% from the previous quarter
LifeMD's net income has surged by 54% YoY and by 43% QoQ
Price vs fundamentals
How does LFMD's price correlate with its fundamentals
Growth
What is LifeMD's growth rate over time
Valuation
What is LifeMD stock price valuation
P/E
N/A
P/B
N/A
P/S
1.98
EV/EBIT
N/A
EV/EBITDA
152.93
EV/Sales
2.04
The EPS has soared by 55% YoY and by 38% from the previous quarter
LifeMD's equity has shrunk by 175% YoY but it has surged by 58% QoQ
The P/S is 65% above the last 4 quarters average of 1.2 and 4.2% above the 5-year quarterly average of 1.9
The revenue has grown by 43% YoY and by 10% from the previous quarter
Efficiency
How efficient is LifeMD business performance
The ROS has soared by 72% YoY and by 56% from the previous quarter
LFMD's ROA has soared by 64% year-on-year and by 40% since the previous quarter
Dividends
What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFMD.
Financial health
How did LifeMD financials performed over time
LFMD's total liabilities is up by 23% year-on-year but it is down by 3.3% since the previous quarter
The quick ratio has contracted by 20% YoY
LifeMD's equity has shrunk by 175% YoY but it has surged by 58% QoQ
LFMD's debt to equity has dropped by 135% since the previous quarter but it has surged by 54% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.